title: Management of urinary tract infection in general practice: a cost-effectiveness analysis.
abstract: BACKGROUND
  Symptoms associated with urinary tract infection (UTI) are common in women in general practice and represent a significant burden for the National Health Service. There is considerable variation among general practitioners in the management of patients presenting with these symptoms.
  
  
  OBJECTIVE
  To identify the most appropriate patient management strategy given current information for non-pregnant, adult women presenting in general practice with symptoms of uncomplicated UTI.
  
  
  METHODS
  A decision analytic model incorporating a variety of patient management strategies was constructed using available published information and expert opinion. This model was able to provide guidance on current best practice based upon cost-effectiveness (cost per symptom-free day).
  
  
  RESULTS
  Empiric treatment was found to be the least costly strategy available. It saved two days of symptoms per episode of UTI at a cost of 14 Pounds. The empiric-and-laboratory strategy involves an incremental cost-effectiveness ratio of 215 Pounds per symptom day averted per episode of UTI. The remaining patient management strategies are never optimal.
  
  
  CONCLUSIONS
  Empiric treatment of patients presenting with symptoms of UTI was found to be cost-effective under a range of assumptions for this patient group. However, recognition of the impact of this strategy upon antibiotic resistance may lead to the dipstick strategy being considered a superior strategy overall.
authors.affiliation: Centre for Health Economics, University of York. ealf100@york.ac.uk
authors.forename: E A
authors.initials: EA
authors.lastname: Fenwick
authors.forename: A H
authors.initials: AH
authors.lastname: Briggs
authors.forename: C I
authors.initials: CI
authors.lastname: Hawke
mesh_terms: D000328:Adult; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D004352:Drug Resistance, Microbial; D005194:Family Practice; D005260:Female; D006801:Humans; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000191:economics / Q000628:therapy*